ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Eyenovia Inc

Eyenovia Inc (EYEN)

0.6282
-0.0831
(-11.68%)
Closed April 27 4:00PM
0.64
0.0118
(1.88%)
After Hours: 7:58PM

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

EYEN News

Official News Only

EYEN Discussion

View Posts
Dennis14 Dennis14 2 weeks ago
I bought in today. Now I’ll sit and wait.
πŸ‘οΈ0
Monksdream Monksdream 2 weeks ago
EYEN new 52 lo
πŸ‘οΈ0
Monksdream Monksdream 3 weeks ago
EYEN new 52 lo
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
EYEN under $2
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
EYEN under $2
πŸ‘οΈ0
glenn1919 glenn1919 2 months ago
EYEN..........................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 2 months ago
EYEN.......................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
EYEN under $2
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
EYEN new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
EYEN new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
EYEN under $2
πŸ‘οΈ0
honest dave honest dave 3 years ago
EYEN --
--Northland Adjusts Eyenovia's Price Target to $9 From $12, Maintains Outperform Rating
BY MT Newswires
β€” 9:31 AM ET 10/26/2021
πŸ‘οΈ0
jdlamont jdlamont 3 years ago
EYEN now trading options!!!!
πŸ‘οΈ0
jdlamont jdlamont 3 years ago
EYEN now trading options!!!!
πŸ‘οΈ0
beambe beambe 4 years ago
Good NEWS
πŸ‘οΈ0
beambe beambe 4 years ago
good Volume
πŸ‘οΈ0
beambe beambe 4 years ago
https://eyenovia.com/about-2019/

πŸ‘οΈ0
ClayTrader ClayTrader 4 years ago
* * $EYEN Video Chart 08-11-2020 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
beambe beambe 4 years ago
good Volume
πŸ‘οΈ0
breezy1 breezy1 4 years ago
OCGN - .62 orphan FDA approvals
πŸ‘οΈ0
crudeoil24 crudeoil24 4 years ago
Eyenovia and Arctic Vision Announce Exclusive Collaboration and License Agreement to Develop and Commercialize MicroPine and MicroLine in Greater China and South Korea
8:05 am ET August 11, 2020 (Globe Newswire) Print
Eyenovia Eligible to Receive up to a Total of $45.75 million in Upfront Payments and Development and Commercialization Milestones and Development Costs

Arctic Vision to Lead Expansion of Novel Approach to Treating Myopia and Presbyopia in Greater China and South Korea

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP(TM)) therapeutics and Arctic Vision, a clinical stage biotech company focused on developing and commercializing innovative ophthalmology therapies in China and Asia, today announced that they have entered into an exclusive license agreement for Arctic Vision to develop and commercialize MicroPine for the treatment of progressive myopia and MicroLine for the treatment of presbyopia in Greater China (mainland China, Hong Kong, Macau and Taiwan) and South Korea.

Under the terms of the agreement, Eyenovia may receive up to a total of $45.75 million in upfront payments as well as additional payments, based on various development and regulatory milestones, including the initiation of clinical research and approvals in Greater China and South Korea, and development costs. In addition, Arctic Vision will purchase its supply of MicroPine and MicroLine from Eyenovia or, for such products not supplied by Eyenovia, pay Eyenovia a mid-single digit percentage royalty on net sales of such products, subject to certain adjustments. Eyenovia will pay a mid-double digit percentage of such payments, royalties, or net proceeds of such supply to its Asian licensee pursuant to the arrangement
πŸ‘οΈ0
BioSpecialist BioSpecialist 4 years ago
next $10 stock soon
πŸ‘οΈ0
BioSpecialist BioSpecialist 4 years ago
STRONG BUY
πŸ‘οΈ0
BioSpecialist BioSpecialist 4 years ago
EYEN = MC $60 Million /NDA submission for BIG drug in Q3 / 2 more Drugs in Phase 3 including a potential Blockbuster /Undiscovered low float gem = A Potential 10+ Bagger Gem ..GLTA



πŸ‘οΈ0
jdlamont jdlamont 4 years ago
anyone who sees the video of the kid using the machine will buy the stock.
So easy and simple to use-REVOLUTIONARY. Very impressive.
πŸ‘οΈ0
ADVFN_bioking ADVFN_bioking 4 years ago
RALLLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY
πŸ‘οΈ0
ADVFN_bioking ADVFN_bioking 4 years ago
looks like next breakout about to start
πŸ‘οΈ0
ADVFN_bioking ADVFN_bioking 4 years ago
Load up before she takes off again
πŸ‘οΈ0
ADVFN_bioking ADVFN_bioking 4 years ago
STRONG BUY this pure undiscovered Goldmine
πŸ‘οΈ0
JGCola JGCola 4 years ago
Down a lot today. I'd say related to ALDX (another "eyes" biotech) which is down about 32% following Top-Line results. It's a mistake to associate the faith of those 2 IMO. This is creating a great opportunity. Will go back over 4$ very soon and may never "look" back. This wild horse will suddenly run free at some point. Great MGT. Founder keeps on buying. Great innovation. First-in-class comes to mind.
πŸ‘οΈ0
jdlamont jdlamont 4 years ago
4 years from now 300 dollar stock when myopia drug approved
πŸ‘οΈ0
ADVFN_bioking ADVFN_bioking 4 years ago
UUUUUUUUUUUUUUUUUUUP again and still terrible undervalued
πŸ‘οΈ0
ADVFN_bioking ADVFN_bioking 4 years ago
BOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM
πŸ‘οΈ0
ADVFN_bioking ADVFN_bioking 4 years ago
$20 stock trading at $3
πŸ‘οΈ0
ADVFN_bioking ADVFN_bioking 4 years ago
mega potential here
πŸ‘οΈ0
ADVFN_bioking ADVFN_bioking 4 years ago
could run fast
πŸ‘οΈ0
ADVFN_bioking ADVFN_bioking 4 years ago
love it
πŸ‘οΈ0
jdlamont jdlamont 5 years ago
Zacks raises stock to BUY today and there is nobody here. Wow.
πŸ‘οΈ0
jdlamont jdlamont 5 years ago
olympus investments takes 70.000 share position
πŸ‘οΈ0
jdlamont jdlamont 5 years ago
200k day, crazy trading swings. should be volume reversal, we shall see.
πŸ‘οΈ0
jdlamont jdlamont 5 years ago
Company is a conduit for drug delivery for every topical eye care drug company in existence, and hence will be bought out.
πŸ‘οΈ0
jdlamont jdlamont 5 years ago
Game of Rogues- 40 cent spread between bid and asked, no law in the Wild West.
πŸ‘οΈ0
jdlamont jdlamont 5 years ago
The undiscovered country.
This is going to be the new application standard for all things eye.
One machine with multi-function use.
Enormous market. one of a kind tech with no competition, as they lead with multiple phase 3 trials, and small cap equals grand slam home run.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock